D P K Ng1, B C Tai, D Koh, K W Tan, K S Chia. 1. Department of Community, Occupational and Family Medicine, Faculty of Medicine (MD3), National University of Singapore, 16 Medical Drive, Singapore 117597, Singapore. cofnpkd@nus.edu.sg
Abstract
AIMS/HYPOTHESIS: The ACE insertion/deletion polymorphism has been examined for association with diabetic nephropathy over the past decade with conflicting results. To clarify this situation, we conducted a comprehensive meta-analysis encompassing all relevant studies that were published between 1994 and 2004 and investigated this potential genetic association. METHODS: A total of 14,727 subjects from 47 studies was included in this meta-analysis. Cases (n=8,663) were type 1 or 2 diabetic subjects with incipient (microalbuminuria) or advanced diabetic nephropathy (proteinuria, chronic renal failure, end-stage renal disease). Control subjects (n=6,064) were predominantly normoalbuminuric. RESULTS: No obvious publication bias was detected. Using a minimal-case definition based on incipient diabetic nephropathy, subjects with the II genotype had a 22% lower risk of diabetic nephropathy than carriers of the D allele (pooled odds ratio [OR]=0.78, 95% CI=0.69-0.88). While there was a reduced risk of diabetic nephropathy associated with the II genotype among Caucasians with either type 1 or type 2 diabetes, the association was most marked among type 2 diabetic Asians (Chinese, Japanese, Koreans) (OR=0.65, 95% CI=0. 51-0.83). This OR is significantly different from the OR of 0.90 (95% CI= 0.78-1.04) that was obtained for type 2 diabetic Caucasians (p=0.019). Using a stricter case definition based on advanced diabetic nephropathy, a comparable risk reduction of 24-32% was observed among the three subgroups, although statistical significance was reached only among Asians. CONCLUSIONS/ INTERPRETATION: The results of our meta-analysis support a genetic association of the ACE Ins/Del polymorphism with diabetic nephropathy. These findings may have implications for the management of diabetic nephropathy using ACE inhibitors especially among type 2 diabetic Asians.
AIMS/HYPOTHESIS: The ACE insertion/deletion polymorphism has been examined for association with diabetic nephropathy over the past decade with conflicting results. To clarify this situation, we conducted a comprehensive meta-analysis encompassing all relevant studies that were published between 1994 and 2004 and investigated this potential genetic association. METHODS: A total of 14,727 subjects from 47 studies was included in this meta-analysis. Cases (n=8,663) were type 1 or 2 diabetic subjects with incipient (microalbuminuria) or advanced diabetic nephropathy (proteinuria, chronic renal failure, end-stage renal disease). Control subjects (n=6,064) were predominantly normoalbuminuric. RESULTS: No obvious publication bias was detected. Using a minimal-case definition based on incipient diabetic nephropathy, subjects with the II genotype had a 22% lower risk of diabetic nephropathy than carriers of the D allele (pooled odds ratio [OR]=0.78, 95% CI=0.69-0.88). While there was a reduced risk of diabetic nephropathy associated with the II genotype among Caucasians with either type 1 or type 2 diabetes, the association was most marked among type 2 diabetic Asians (Chinese, Japanese, Koreans) (OR=0.65, 95% CI=0. 51-0.83). This OR is significantly different from the OR of 0.90 (95% CI= 0.78-1.04) that was obtained for type 2 diabetic Caucasians (p=0.019). Using a stricter case definition based on advanced diabetic nephropathy, a comparable risk reduction of 24-32% was observed among the three subgroups, although statistical significance was reached only among Asians. CONCLUSIONS/ INTERPRETATION: The results of our meta-analysis support a genetic association of the ACE Ins/Del polymorphism with diabetic nephropathy. These findings may have implications for the management of diabetic nephropathy using ACE inhibitors especially among type 2 diabetic Asians.
Authors: T A Chowdhury; M J Dronsfield; S Kumar; S L Gough; S P Gibson; A Khatoon; F MacDonald; B R Rowe; D B Dunger; J D Dean; S J Davies; J Webber; P R Smith; P Mackin; S M Marshall; D Adu; P J Morris; J A Todd; A H Barnett; A J Boulton; S C Bain Journal: Diabetologia Date: 1996-09 Impact factor: 10.122
Authors: T Oue; M Namba; H Nakajima; A Ono; Y Horikawa; K Yamamoto; T Hamaguchi; H Fujino-Kurihara; T Yamasaki; K Tomita; J Miyagawa; T Hanafusa; Y Matsuzawa Journal: Diabetes Res Clin Pract Date: 1999-10 Impact factor: 5.602
Authors: S K Ha; S Yong Lee; H Su Park; J Ho Shin; S Jung Kim; D Hun Kim; K Rae Kim; H Yung Lee; D Suk Han Journal: Nephrol Dial Transplant Date: 2000-10 Impact factor: 5.992
Authors: H Yoshida; S Kuriyama; Y Atsumi; H Tomonari; T Mitarai; A Hamaguchi; H Kubo; Y Kawaguchi; V Kon; K Matsuoka; I Ichikawa; O Sakai Journal: Kidney Int Date: 1996-08 Impact factor: 10.612
Authors: S Hadjadj; Y Gallois; F Alhenc-Gelas; G Chatellier; M Marre; N Genes; M Lievre; J Mann; J Menard; D Vasmant Journal: Diabet Med Date: 2003-08 Impact factor: 4.359
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: A Titia Lely; Frank G H van der Kleij; Taco J Kistemaker; Alfred J Apperloo; Paul E de Jong; Dick de Zeeuw; Gerjan Navis Journal: Clin J Am Soc Nephrol Date: 2007-12-12 Impact factor: 8.237
Authors: Hussam Al-Kateb; Andrew P Boright; Lucia Mirea; Xinlei Xie; Rinku Sutradhar; Alireza Mowjoodi; Bhupinder Bharaj; Michelle Liu; Jean M Bucksa; Valerie L Arends; Michael W Steffes; Patricia A Cleary; Wanjie Sun; John M Lachin; Paul S Thorner; Michael Ho; Amy Jayne McKnight; A Peter Maxwell; David A Savage; Kenneth K Kidd; Judith R Kidd; William C Speed; Trevor J Orchard; Rachel G Miller; Lei Sun; Shelley B Bull; Andrew D Paterson Journal: Diabetes Date: 2007-10-03 Impact factor: 9.461
Authors: Marko Mrkobrada; Heather Thiessen-Philbrook; R Brian Haynes; Arthur V Iansavichus; Faisal Rehman; Amit X Garg Journal: Clin J Am Soc Nephrol Date: 2008-04-09 Impact factor: 8.237